4.6 Editorial Material

Insights From Autopsies Potential Role of Thrombus in Structural Valve Deterioration

Journal

JACC-CARDIOVASCULAR IMAGING
Volume 12, Issue 1, Pages 146-148

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jcmg.2018.06.027

Keywords

HALT; TAVR; thrombosis

Funding

  1. Abbott
  2. Daiichi Sankyo
  3. Boehringer Ingelheim
  4. Bayer
  5. Amarin
  6. Amgen
  7. AstraZeneca
  8. Bristol-Myers Squibb
  9. Chiesi
  10. Eisai
  11. Ethicon
  12. Forest Laboratories
  13. Idorsia
  14. Ironwood
  15. Ischemix
  16. Lilly
  17. Medtronic
  18. PhaseBio
  19. Pfizer
  20. Regeneron
  21. Roche
  22. Sanofi Aventis
  23. Synaptic
  24. The Medicines Company

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available